Rafael Holdings Corp - RFL Earnings per share for the trailing year

Stable cash flow from real estate rentals and biotech assets supports the financial stability of Rafael Holdings, Inc. (RFL). The EPS (TTM) market trend has recorded a figure of 43.60. The business relies on the development of robotic systems in medicine to optimize costs, while also serving as an accelerator for transforming bold scientific hypotheses into applied therapeutic solutions and commercial products.
rafaelholdings.com - analytical breakdowns and key metrics (RFL)

Year-over-year (YoY) EPS growth (TTM) measures the trend of net income per share over the last twelve months relative to the same period last year, reflecting profit generation efficiency. By analyzing the relative change in EPS YoY (TTM), an investor assesses the resilience of Rafael Holdings, Inc. (RFL), where pharmaceutical stability balances the sensitivity of commercial real estate to macroeconomic fluctuations.